3 completed, 1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Prostate Cancer, Hereditary, 7: new trials by email Literature Review of Prostate Cancer, Hereditary, 7 trials Research Report on Prostate Cancer, Hereditary, 7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer Accurate Prediction Artificial Intelligence Models - Prostate Cancer, Prostate Intraductal Carcinoma | Not applicable | Not yet recruiting | Shao Pengfei | 200 | 2024-12-01 | 2024-10-29 |
| An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum Magnetic Resonance Imaging - Prostate Cancer, Prostate Cancer Metastatic | Completed | Fondazione del Piemonte per l'Oncologia | 14000 | 2021-02-24 | 2026-06-04 | |
| Active Surveillance SNEP Assay Registry Trial for Prostate Cancer Subtraction Normalized Expression of Phagocytes Blood Test - Prostate Cancer Aggressiveness | Recruiting | Immunis.AI | 2000 | 2019-09-09 | 2026-04-02 | |
| Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC Cabazitaxel, Carboplatin, Prednisone 5Mg - Prostate Cancer Aggressiveness, Prostate Carcinoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 96 | 2017-10-03 | 2026-06-17 |
| Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer Magnetic Resonance Spectroscopy Imaging with rectal probe - Prostate Cancer | Completed | OHSU Knight Cancer Institute | 66 | 2013-01-01 | 2017-04-27 |
Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Prostatic Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4)
Carboplatin (1) · Magnetic Resonance Imaging (1) · Magnetic Resonance Spectroscopy (1) · Prednisone (1) · cabazitaxel (1) · olaparib (1)
Fondazione del Piemonte per l'Oncologia (1) · Immunis.AI (1) · M.D. Anderson Cancer Center (1) · OHSU Knight Cancer Institute (1) · Shao Pengfei (1)
United States (3) · China (1) · Italy (1)
Ana M. Aparicio, MD (1) · Jackilen Shannon, PhD (1) · Jonathan Q Purnell, MD (1) · Kostantinos Marias (1) · Manolis Tsiknakis (1) · Nickolas Papanikolau (1)